Detailed Introduction Specializing in precision treatment and minimally invasive surgery for thoracic tumors, with expertise in minimally invasive thoracoscopic surgery and conventional open-chest surgery for lung, esophageal, mediastinal tumors, empyema, tracheal tumors, pneumothorax, and other diseases. Extensive experience has been accumulated in multiple subspecialties. In the field of chest wall deformity treatment, continuous innovation and in-depth research have been pursued: For pectus excavatum, the "Nihao Micro-Stable (Ultra-Minimally Invasive + Ultra-Stable) Surgery" has been developed. By employing the core technique of not flipping the correction plate during surgery, surgical trauma is significantly reduced. Meanwhile, the ultra-stable fixation design effectively lowers the risk of implant plate displacement, fundamentally preventing deformity recurrence and the physical and psychological trauma associated with secondary surgery. This technique has achieved leading domestic and international standards. For pectus carinatum, a custom-designed correction plate has been independently developed and successfully applied in clinical practice, significantly simplifying the surgical procedure, reducing surgical trauma, and completely resolving the issue of correction failure caused by wire breakage in traditional surgery, thereby solidifying the diagnostic and therapeutic advantages in this field. Additionally, emphasis is placed on the standardized management of pulmonary GGO (ground-glass opacities). Through precise recording and analysis, individualized and accurate diagnostic and treatment strategies are formulated for patients. Expertise extends to secondary thoracic surgeries, downstaged lung cancer surgeries following targeted/immunotherapy, and complex and difficult thoracic surgical procedures. Comprehensive lung cancer treatment is also proficiently managed, integrating targeted therapy, chemotherapy, immunotherapy, and other modalities to establish a holistic treatment system for patients. In the treatment of palmar and axillary hyperhidrosis, thoracoscopic bilateral sympathectomy is performed, achieving an efficacy rate of 99%-100%. Both the volume of surgeries and treatment outcomes rank among the top in the country, providing relief for numerous patients.